State of the art: Using natriuretic peptide levels in clinical practice

VA San Diego Healthcare System Cardiology, San Diego, CA 92161, USA.
European Journal of Heart Failure (Impact Factor: 6.58). 09/2008; 10(9):824-39. DOI: 10.1016/j.ejheart.2008.07.014
Source: PubMed

ABSTRACT Natriuretic peptide (NP) levels (B-type natriuretic peptide (BNP) and N-terminal proBNP) are now widely used in clinical practice and cardiovascular research throughout the world and have been incorporated into most national and international cardiovascular guidelines for heart failure. The role of NP levels in state-of-the-art clinical practice is evolving rapidly. This paper reviews and highlights ten key messages to clinicians: 1) NP levels are quantitative plasma biomarkers of heart failure (HF). 2) NP levels are accurate in the diagnosis of HF. 3) NP levels may help risk stratify emergency department (ED) patients with regard to the need for hospital admission or direct ED discharge. 4) NP levels help improve patient management and reduce total treatment costs in patients with acute dyspnoea. 5) NP levels at the time of admission are powerful predictors of outcome in predicting death and re-hospitalisation in HF patients. 6) NP levels at discharge aid in risk stratification of the HF patient. 7) NP-guided therapy may improve morbidity and/or mortality in chronic HF. 8) The combination of NP levels together with symptoms, signs and weight gain assists in the assessment of clinical decompensation in HF. 9) NP levels can accelerate accurate diagnosis of heart failure presenting in primary care. 10) NP levels may be helpful to screen for asymptomatic left ventricular dysfunction in high-risk patients.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost. However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy. The healthcare team must often individualize patient care in ways that may extend beyond available clinical guidelines. In this review, we address the question, "How do you do the best you can clinically with incomplete evidence and imperfect drugs?" Expert opinion is provided to supplement guideline-based recommendations and help address the typical challenges that are involved in the management of patients with acute heart failure. Specifically, we discuss 4 key areas that are important in the continuum of patient care: differential diagnosis and risk stratification; choice and implementation of initial therapy; assessment of the adequacy of therapy during hospitalization or observation; and considerations for discharge/transition of care. A case study is presented to highlight the decision-making process throughout each of these areas. Evidence is accumulating that should help guide patients and healthcare providers on a path to better quality of care.
  • Notfall 06/2014; 17(4):287-292. DOI:10.1007/s10049-013-1781-z · 0.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute heart failure (HF) is common in the elderly, but the association of age with clinical outcomes and prognostic factors has not been examined thoroughly. We have analyzed the clinical and laboratory characteristics and the outcomes of 1347 patients with acute HF enrolled in the VERITAS trial. Subjects were subdivided based on their median age of 72 years. Older patients had a higher prevalence of comorbidities and a higher prevalence of hypertension and atrial fibrillation. During a mean follow-up of 149 ± 61days, 432 (32.1%) patients reached the composite endpoint of death, in-hospital worsening HF (WHF) or HF rehospitalization by 30 days and 135 (10.4%) patients died by 90 days with a worse outcome in elderly patients in both cases. At multivariable analysis, different variables were related with each of these outcomes in elderly, compared with younger patients. With respect to deaths at 90 days, plasma urea nitrogen and hemoglobin levels were predictive only in the younger patients, whereas respiratory rate and albumin levels were associated with mortality only in the older ones. Elderly patients with acute heart failure have different clinical characteristics and poorer outcomes. Prognostic variables differ in elderly, compared with younger, patients. Copyright © 2014 Elsevier Inc. All rights reserved.
    Journal of Cardiac Failure 01/2015; DOI:10.1016/j.cardfail.2014.12.012 · 3.07 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014